Contact Us | Directions | Referring a Patient

A leading comprehensive brain tumor program, using molecular diagnostic, gene expression analysis,
cutting edge clinical trials and advanced medical informatics to customize treatment plans for cancer patients.
 Latest Headlines
New hope for children with brain tumors | Harvard Gazette
Thu, 19 Jan 2017 18:32:03 GMT (Harvard Gazette)
Tumor-Seeking Salmonella Treats Brain Tumors | Duke Pratt School ...
Wed, 11 Jan 2017 16:49:20 GMT (Duke Today)
New Hampshire family plans bucket list for 9-year-old with terminal ...
Fri, 13 Jan 2017 14:20:13 GMT (Fox News)
Daughter of NKY firefighters fights inoperable brain tumor
Mon, 16 Jan 2017 23:12:39 GMT (WLWT Cincinnati)
Glioblastoma Treatment Breakthrough: 'Untreatable' Brain Cancer Tumor Stabilized With Malaria Drug
Tue, 17 Jan 2017 19:19:11 GMT (Medical Daily)
Brain cancer survivor to attempt 7 marathons in 7 days
Thu, 19 Jan 2017 22:31:30 GMT (
Salmonella Has Been Genetically Engineered to Consume Brain Tumors
Fri, 13 Jan 2017 15:17:59 GMT (Futurism)
Family optimistic after CHaD doctors remove 90 percent of girl's brain tumor
Mon, 16 Jan 2017 20:58:28 GMT (WMUR Manchester)
Family plans bucket list for 9-year-old with terminal brain tumor ...
Thu, 12 Jan 2017 22:40:31 GMT (My Fox Boston)
Precision medicine advances pediatric brain tumor diagnosis and treatment
Thu, 19 Jan 2017 09:10:00 GMT (EurekAlert (press release))
1/23/2017 12:21:54 PM
Feed cached:1/23/2017 12:21:54 PM

* Headlines are from industry sponsored news wires, medical journals and established news organizations from around the world . Please consider the source of the content when viewing the story.
Dani Saleh Brain Cancer Research Fund at UCLA

The Dani Saleh Brain Cancer Research Fund supports the brain cancer research collaboration between Dr. Timothy Cloughesy and Dr. Stan Nelson. This fund will directly support the work and training of a research fellow in Dr. Stan Nelson’s lab.

Dr. Nelson is Professor and Vice Chair of Human Genetics and Professor of Psychiatry at the David Geffen School of Medicine at UCLA.

UCLA Neuro-Oncology & SiliconMED Launch Online Tool Correlating Gene Expression Levels with Overall Survival of Brain Cancer Patients

Genomic analysis is a powerful new tool permitting unprecedented insights into how brain tumors form and has been enabled primarily through microarray technology., a new web based tool, is aiming to help clinicians and researchers take the massive amount of data created by microarrays and better visualize gene expression levels and how they relate to the overall survival of brain cancer patients.

Most Popular
. Clinical Trials
. Probe Set Analyzer
. Our Team
. Brain Tumor Translational Resource
. Art of the Brain
. Personalized Medicine using Targeted Molecular Therapy
. Online Giving
. How our Glioblastoma Multiforme Patients Perform
Neuro-Oncology on Facebook

Spring/Summer 2014
UCLA Neuro-Oncology : Breakthroughs Spotlighting new discovery in brain cancer research.

It is time to include patients with brain tumors in phase I trials in oncology.
J Clin Oncol.

Graded functional diffusion map-defined characteristics of apparent diffusion coefficients predict overall survival in recurrent glioblastoma treated with bevacizumab.
Neuro Oncol.

Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma.
Neuro Oncol.

Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment delivery.
J Neurooncol.

Phase II study of aflibercept in recurrent malignant glioma: a north american brain tumor consortium study.
J Clin Oncol.

All Information content hearof is designed for educational purposes only and is not for the purpose of rendering medical advice or professional services. The information provided should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. Any specific questions you may have regarding an individual's medical condition should be directed to the individual's primary care physician or other attending physician. In addition, if you have or suspect you may have a health problem, you should consult your health care provider.

Portions Copyright (Search, Chart, Content Publishing Tools, Photography, ProviderIQ) 1998-2017 SiliconMED North America

ProviderIQ is a registered trademark of SiliconMED North America and used by permission.

Copyright © 2017 UCLA Neuro-Oncology Program | Timothly Cloughesy MD; Director
All Rights Reserved.

[Content Published:1/23/2017 12:21:54 PM PST]